Eintrag weiter verarbeiten

A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the pre...

Gespeichert in:

Veröffentlicht in: Blood 124(2014,21) Artikel-Nr. 5946, 1 S.
Personen und Körperschaften: Cornely, Oliver Andreas (Sonstige), Heußel, Claus Peter (Sonstige)
Titel: A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial)/ Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget
Format: E-Book-Kapitel
Sprache: Englisch
veröffentlicht:
2014
Gesamtaufnahme: : Blood, 124(2014,21) Artikel-Nr. 5946, 1 S.
, volume:124
Quelle: Verbunddaten SWB
Lizenzfreie Online-Ressourcen
LEADER 02409caa a2200517 4500
001 0-1504683013
003 DE-627
005 20220812011750.0
007 cr uuu---uuuuu
008 150630s2014 xx |||||o 00| ||eng c
035 |a (DE-627)1504683013 
035 |a (DE-576)434683019 
035 |a (DE-599)BSZ434683019 
035 |a (OCoLC)1340697011 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
245 1 2 |a A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial)  |c Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget 
264 1 |c 2014 
300 |a 1 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.06.2015 
700 1 |a Cornely, Oliver Andreas  |d 1967-  |0 (DE-588)121712915  |0 (DE-627)081485123  |0 (DE-576)292844425  |4 oth 
700 1 |a Heußel, Claus Peter  |0 (DE-588)1048631389  |0 (DE-627)780769422  |0 (DE-576)40288146X  |4 oth 
773 0 8 |i In  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 124(2014,21) Artikel-Nr. 5946, 1 S.  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnns 
773 1 8 |g volume:124  |g year:2014  |g number:21  |g extent:1 
856 4 0 |u https://ash.confex.com/ash/2014/webprogram/Session5946.html/  |x Verlag  |z kostenfrei  |3 Volltext 
936 u w |d 124  |j 2014  |e 21  |g 1  |y 124(2014,21) Artikel-Nr. 5946, 1 S. 
951 |a AR 
856 4 0 |u https://ash.confex.com/ash/2014/webprogram/Session5946.html/  |9 LFER 
852 |a LFER  |z 2017-09-14T00:00:00Z 
970 |c OD 
971 |c EBOOK 
972 |c EBOOK 
973 |c Aufsatz 
935 |a lfer 
900 |a Heußel, Claus P. 
900 |a Heußel, C. P. 
900 |a Heussel, Claus Peter 
900 |a Heussel, Claus-Peter 
900 |a Heussel, Claus P. 
900 |a Cornely, Oliver A. 
900 |a Cornely, Oliver 
900 |a Cornely, O. A. 
980 |a 1504683013  |b 0  |k 1504683013  |o 434683019  |c lfer 
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+double-blind%2Cmulticentre%2C+randomised%2C+placebo-controlled+study+to+assess+the+efficacy%2C+safety+and+tolerability+of+prophylactic+liposomal+Amphotericin+B+%28AmBisome+%28R%29%29+for+the+prevention+of+invasive+fungal+infections+in+subjects+receiving+remission-induction+chemotherapy+for+acute+lymphoblastic+leukaemia+%28AmBiGuard+trial%29&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=1528-0020
SOLR
_version_ 1757940088777474048
access_facet Electronic Resources
author2 Cornely, Oliver Andreas, Heußel, Claus Peter
author2_role oth, oth
author2_variant o a c oa oac, c p h cp cph
author_facet Cornely, Oliver Andreas, Heußel, Claus Peter
callnumber-sort
collection lfer
container_reference 124(2014,21) Artikel-Nr. 5946, 1 S.
container_title Blood
ctrlnum (DE-627)1504683013, (DE-576)434683019, (DE-599)BSZ434683019, (OCoLC)1340697011
facet_avail Online, Free
finc_class_facet not assigned
finc_id_str 0019909968
footnote Gesehen am 30.06.2015
format ElectronicBookComponentPart
format_access_txtF_mv Article, E-Article
format_de105 Ebook
format_de14 Article, E-Article
format_de15 Article, E-Article
format_del152 Buch
format_detail_txtF_mv text-online-monograph-child
format_dezi4 e-Book
format_finc Article, E-Article
format_legacy ElectronicBookPart
format_strict_txtF_mv E-Article
geogr_code not assigned
geogr_code_person not assigned
hierarchy_parent_id 0-266886647
hierarchy_parent_title Blood
hierarchy_sequence 124(2014,21) Artikel-Nr. 5946, 1 S.
hierarchy_top_id 0-266886647
hierarchy_top_title Blood
id 0-1504683013
illustrated Not Illustrated
imprint 2014
imprint_str_mv 2014
institution DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2
is_hierarchy_id 0-1504683013
is_hierarchy_title A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial)
isil_str_mv LFER
issn 1528-0020
kxp_id_str 1504683013
language English
last_indexed 2023-02-15T23:05:11.823Z
match_str cornely2014adoubleblindmulticentrerandomisedplacebocontrolledstudytoassesstheefficacysafetyandtolerabilityofprophylacticliposomalamphotericinbambisomerforthepreventionofinvasivefungalinfectionsinsubjectsreceivingremissioninductionchemotherapyforacutelymphoblasticleukaemiaambiguardtrial
mega_collection Verbunddaten SWB, Lizenzfreie Online-Ressourcen
misc_de105 EBOOK
multipart_link 075961938
multipart_part (075961938)124(2014,21) Artikel-Nr. 5946, 1 S.
names_id_str_mv (DE-588)121712915, (DE-627)081485123, (DE-576)292844425, (DE-588)1048631389, (DE-627)780769422, (DE-576)40288146X
oclc_num 1340697011
physical 1
publishDate 2014
publishDateSort 2014
publishPlace
publisher
record_format marcfinc
record_id 434683019
recordtype marcfinc
rvk_facet No subject assigned
source_id 0
spelling A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget, 2014, 1, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Gesehen am 30.06.2015, Cornely, Oliver Andreas 1967- (DE-588)121712915 (DE-627)081485123 (DE-576)292844425 oth, Heußel, Claus Peter (DE-588)1048631389 (DE-627)780769422 (DE-576)40288146X oth, In Blood Washington, DC : American Society of Hematology, 1946 124(2014,21) Artikel-Nr. 5946, 1 S. Online-Ressource (DE-627)266886647 (DE-600)1468538-3 (DE-576)075961938 1528-0020 nnns, volume:124 year:2014 number:21 extent:1, https://ash.confex.com/ash/2014/webprogram/Session5946.html/ Verlag kostenfrei Volltext, https://ash.confex.com/ash/2014/webprogram/Session5946.html/ LFER, LFER 2017-09-14T00:00:00Z
spellingShingle A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial)
swb_id_str 434683019
title A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial)
title_auth A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial)
title_full A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget
title_fullStr A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget
title_full_unstemmed A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget
title_in_hierarchy A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) / Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget,
title_short A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial)
title_sort double blind multicentre randomised placebo controlled study to assess the efficacy safety and tolerability of prophylactic liposomal amphotericin b ambisome r for the prevention of invasive fungal infections in subjects receiving remission induction chemotherapy for acute lymphoblastic leukaemia ambiguard trial
url https://ash.confex.com/ash/2014/webprogram/Session5946.html/